Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy

Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy

Background:18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging is not routine in patients with localized pancreatic cancer (PC). We evaluated the prognostic value of PET/CT in patients who received neoadjuvant therapy.Methods: Patients with localized PC underwent...

Full description

Bibliographic Details
Main Authors: Chad A. Barnes, Mohammed Aldakkak, Callisia N. Clarke, Kathleen K. Christians, Daniel Bucklan, Michael Holt, Parag Tolat, Paul S. Ritch, Ben George, William A. Hall, Beth A. Erickson, Douglas B. Evans, Susan Tsai
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
neoadjuvant therapy
carbohydrate antigen 19-9
18F-fluorodeoxyglucose positron emission tomography
SUV
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00500/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00500/full

Similar Items